eckol has been researched along with aloe emodin in 1 studies
| Studies (eckol) | Trials (eckol) | Recent Studies (post-2010) (eckol) | Studies (aloe emodin) | Trials (aloe emodin) | Recent Studies (post-2010) (aloe emodin) |
|---|---|---|---|---|---|
| 47 | 0 | 32 | 294 | 0 | 166 |
| Protein | Taxonomy | eckol (IC50) | aloe emodin (IC50) |
|---|---|---|---|
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | 2.88 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.77 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, HJ; Kim, D; Kim, JH; Kim, YM; Kwon, HJ; Kwon, JM; Lee, WS; Park, JY; Ryu, YB | 1 |
1 other study(ies) available for eckol and aloe emodin
| Article | Year |
|---|---|
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.
Topics: Antiviral Agents; Benzofurans; Cysteine Proteases; Cysteine Proteinase Inhibitors; Humans; Molecular Docking Simulation; Phaeophyceae; Quantitative Structure-Activity Relationship; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus | 2013 |